Yang Lu

1.8k total citations
105 papers, 1.5k citations indexed

About

Yang Lu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yang Lu has authored 105 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Oncology and 27 papers in Pharmacology. Recurrent topics in Yang Lu's work include Drug Transport and Resistance Mechanisms (20 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Anesthesia and Neurotoxicity Research (11 papers). Yang Lu is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Anesthesia and Neurotoxicity Research (11 papers). Yang Lu collaborates with scholars based in China, United States and Japan. Yang Lu's co-authors include Xijing Chen, Di Zhao, Haiying Sun, Ning Li, Boyang Yu, Ning Li, Chengzhi Chai, Di Zhao, Yue Yang and Xinlin Chen and has published in prestigious journals such as ACS Applied Materials & Interfaces, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Yang Lu

101 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Lu China 23 462 250 217 211 143 105 1.5k
Lin Ma China 27 872 1.9× 250 1.0× 210 1.0× 171 0.8× 45 0.3× 105 2.0k
Qing Zhu China 23 742 1.6× 159 0.6× 206 0.9× 110 0.5× 47 0.3× 95 1.7k
Daiying Zuo China 28 950 2.1× 67 0.3× 182 0.8× 333 1.6× 89 0.6× 104 2.5k
Ashif Iqubal India 23 544 1.2× 116 0.5× 148 0.7× 136 0.6× 28 0.2× 71 1.7k
Chuwen Li China 28 777 1.7× 183 0.7× 162 0.7× 104 0.5× 30 0.2× 79 1.9k
Syed Shadab Raza India 31 1.0k 2.3× 165 0.7× 268 1.2× 188 0.9× 47 0.3× 78 2.9k
Nina Kaludercic Italy 31 1.6k 3.6× 198 0.8× 123 0.6× 129 0.6× 86 0.6× 47 3.5k
Channy Park South Korea 26 918 2.0× 116 0.5× 205 0.9× 216 1.0× 32 0.2× 57 2.1k

Countries citing papers authored by Yang Lu

Since Specialization
Citations

This map shows the geographic impact of Yang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Lu more than expected).

Fields of papers citing papers by Yang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Lu. The network helps show where Yang Lu may publish in the future.

Co-authorship network of co-authors of Yang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Lu. A scholar is included among the top collaborators of Yang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Lu. Yang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Haibo, et al.. (2025). Analysis of Differences in Volatile Components of Five Lauraceae Plants From Different Genera Based on HS‐SPME‐GC‐MS. Journal of Analytical Methods in Chemistry. 2025(1). 9045731–9045731. 1 indexed citations
2.
Lu, Yang, et al.. (2025). The inhibition of PPARα protein degradation alleviates the cardiotoxicity of Tiebangchui by regulating fatty acid metabolism. Journal of Ethnopharmacology. 348. 119838–119838. 1 indexed citations
4.
Zheng, Juan, Wei Zhao, Kuan Yang, et al.. (2021). Neural Stem Cell-Laden Self-Healing Polysaccharide Hydrogel Transplantation Promotes Neurogenesis and Functional Recovery after Cerebral Ischemia in Rats. ACS Applied Bio Materials. 4(4). 3046–3054. 8 indexed citations
5.
He, Guangli, Ning Xu, Haoying Ge, et al.. (2021). Red-Light-Responsive Ru Complex Photosensitizer for Lysosome Localization Photodynamic Therapy. ACS Applied Materials & Interfaces. 13(17). 19572–19580. 59 indexed citations
6.
Ren, Guanghui, Huili Chen, Yang Lu, et al.. (2020). Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid. Chemico-Biological Interactions. 324. 109097–109097. 11 indexed citations
8.
Li, Jiaming, Xiaoqian Wang, Ning Chen, et al.. (2020). Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects. European Journal of Clinical Pharmacology. 76(8). 1125–1133. 14 indexed citations
9.
Zhang, Qing, Jinfeng Liu, Yongjie Zhang, et al.. (2019). Oroxylin A, a methylated metabolite of baicalein, exhibits a stronger inhibitory effect than baicalein on the CYP1B1‐mediated carcinogenic estradiol metabolite formation. Phytotherapy Research. 33(4). 1033–1043. 14 indexed citations
11.
Lu, Xiaoyu, Min Fang, Yue Yang, et al.. (2019). PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy. Drug Delivery and Translational Research. 10(1). 122–135. 20 indexed citations
12.
Yang, Zhongjie, Yang Lu, Yongjie Zhang, et al.. (2019). A validated UPLC-MS/MS method for determination of tebipenem in human plasma and its application to a pharmacokinetic study in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis. 170. 30–39. 6 indexed citations
13.
Dong, Jing, Wei Xiong, Yuancheng Chen, et al.. (2016). Optimal dosing regimen of biapenem in Chinese patients with lower respiratory tract infections based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation. International Journal of Antimicrobial Agents. 47(3). 202–209. 13 indexed citations
14.
Zhang, Qiuyang, Wei Yang, Hui Wu, et al.. (2014). Tissue distribution and ontogeny of multidrug resistance protein 2, a phosphatidylcholine translocator, in rats. European Journal of Drug Metabolism and Pharmacokinetics. 41(1). 87–91. 1 indexed citations
15.
Li, Ning, Zhixia Qiu, Tingting Li, et al.. (2013). Pharmacokinetics in Sprague-Dawley rats and Beagle dogs andin vitrometabolism of ZJM-289, a novel nitric dioxide donor. Xenobiotica. 44(1). 59–69. 1 indexed citations
16.
He, Jiake, Zhixia Qiu, Ning Li, et al.. (2011). Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. European Journal of Clinical Pharmacology. 67(7). 701–707. 29 indexed citations
17.
Du, Shouying, et al.. (2010). Impact of notoginseng total saponin on intestinal absorption kinetics of jasminoidin. Zhonghua zhongyiyao zazhi. 25(3). 459–462. 2 indexed citations
18.
Jiang, Tao, Zhengxing Rong, Peng Liang, et al.. (2010). Simultaneous determination of citalopram and its metabolite in human plasma by LC–MS/MS applied to pharmacokinetic study. Journal of Chromatography B. 878(5-6). 615–619. 22 indexed citations
19.
Wu, Lei, Ge Zhang, Qin Lü, et al.. (2009). Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats. Drug Development and Industrial Pharmacy. 0(0). 1131872237–9. 10 indexed citations
20.
Lu, Yang. (2005). Quantitative Determination of Sophoricoside in Rat Plasma by HPLC. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026